Tianjin Kangzhe Pharmaceutical Technology

Tianjin Kangzhe Pharmaceutical Technology is a key subsidiary of China Medical System Holdings (CMS), a leading specialty pharmaceutical company focused on the Chinese market. The company operates as a platform for the research, development, and registration of innovative drugs, particularly in the fields of dermatology, ophthalmology, and medical aesthetics. It plays a critical role in CMS's strategy of transitioning from a pure commercialization partner to an innovation-driven pharmaceutical group by managing clinical trials and regulatory affairs in China. The company's portfolio includes a mix of high-growth marketed products and a robust pipeline of late-stage candidates licensed from global partners.